JPS5035316A - - Google Patents

Info

Publication number
JPS5035316A
JPS5035316A JP49037731A JP3773174A JPS5035316A JP S5035316 A JPS5035316 A JP S5035316A JP 49037731 A JP49037731 A JP 49037731A JP 3773174 A JP3773174 A JP 3773174A JP S5035316 A JPS5035316 A JP S5035316A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP49037731A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5035316A publication Critical patent/JPS5035316A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
JP49037731A 1973-04-04 1974-04-03 Pending JPS5035316A (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22595/73A IT1053718B (it) 1973-04-04 1973-04-04 Metodo per prolungare l azione di farmaci attraverso la formazione di composti mcromolecolari

Publications (1)

Publication Number Publication Date
JPS5035316A true JPS5035316A (it) 1975-04-04

Family

ID=11198242

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49037731A Pending JPS5035316A (it) 1973-04-04 1974-04-03

Country Status (5)

Country Link
JP (1) JPS5035316A (it)
BE (1) BE813251A (it)
DE (1) DE2413512A1 (it)
FR (1) FR2224164A1 (it)
IT (1) IT1053718B (it)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152820A (ja) * 1982-03-04 1983-09-10 Kyosei Seiyaku Kk 癌治療用組成物
JPS62129226A (ja) * 1985-11-29 1987-06-11 バイオマトリツクス、インコ−ポレ−テツド 不溶性ヒアルロナン、溶解性ハイラン及びそれらの塩に基づく徐放性製剤とその製造法
WO1992014759A1 (en) * 1991-02-21 1992-09-03 Drug Delivery System Institute, Ltd. Carboxymethylmannoglucan and derivative thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
US9700599B2 (en) 2012-11-13 2017-07-11 Adocia Rapid-acting insulin formulation comprising a substituted anionic compound
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152820A (ja) * 1982-03-04 1983-09-10 Kyosei Seiyaku Kk 癌治療用組成物
JPS62129226A (ja) * 1985-11-29 1987-06-11 バイオマトリツクス、インコ−ポレ−テツド 不溶性ヒアルロナン、溶解性ハイラン及びそれらの塩に基づく徐放性製剤とその製造法
WO1992014759A1 (en) * 1991-02-21 1992-09-03 Drug Delivery System Institute, Ltd. Carboxymethylmannoglucan and derivative thereof

Also Published As

Publication number Publication date
IT1053718B (it) 1981-10-10
FR2224164A1 (en) 1974-10-31
DE2413512A1 (de) 1974-10-24
BE813251A (fr) 1974-07-31

Similar Documents

Publication Publication Date Title
AU476761B2 (it)
AU465372B2 (it)
AU474593B2 (it)
AU474511B2 (it)
AU474838B2 (it)
AU465453B2 (it)
AU471343B2 (it)
AU465434B2 (it)
AU450229B2 (it)
AU476714B2 (it)
AU466283B2 (it)
AU476696B2 (it)
AU472848B2 (it)
AU477823B2 (it)
AR195311A1 (it)
AU471461B2 (it)
AR193950A1 (it)
AU447540B2 (it)
AU477824B2 (it)
AU461342B2 (it)
AU476873B1 (it)
AR195948A1 (it)
AR196123Q (it)
AR196212Q (it)
BG19649A1 (it)